T0	Participants 83 120	patients with chronic kidney disease.
T1	Participants 176 234	patients with chronic kidney disease (CKD) not on dialysis
T2	Participants 681 707	non-dialysis CKD patients.
T3	Participants 750 868	subgroup of patients from a study that evaluated the impact of two phosphorus binder regimens on hard outcomes in CKD.
T4	Participants 869 958	Patients (n = 113) with stage 3-4 CKD and evidence of CAC on a phosphorus-restricted diet
T5	Participants 1978 1990	CKD patients